Johanna L. Hannan

Johanna L. Hannan

Auto-generated profile, based on publicly available information

Johanna L. Hannan

Department of Physiology, Brody School of Medicine, East Carolina University, Greenville, NC, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2014 in Nature Reviews Urology
Verified
Journal Article
Open access
PDF file
NSNikolai A. Sopko
Nikolai A. Sopko
JHJohanna L. Hannan
Johanna L. Hannan
TBTrinity J. Bivalacqua
Trinity J. Bivalacqua
RhoA–ROCK signalling is important for erectile homeostasis, and acts by potentiating Ca2+-dependent contraction to maintain penile flaccidity Dysregulation of the RhoA–ROCK pathway has an important role in the aetiology of erectile dysfunction RhoA–ROCK inhibition improves erectile dysfunction, even for hard-to-treat causes, such as diabetes Several RhoA–ROCK inhibitors are being investigated in clinical trials and could provide new treatment options

1 March 2009 in The Journal of Sexual Medicine
Verified
Journal Article
Closed access
PDF file
JHJohanna L. Hannan
Johanna L. Hannan
MMM. Tina Maio
M. Tina Maio
MKMarina Komolova
Marina Komolova
MAMichael Adams
Michael Adams

19 February 2018 in Toxicological Sciences
Verified
Journal Article
Closed access
PDF file
BKBrita Kilburg-Basnyat
Brita Kilburg-Basnyat
SRSky W Reece
Sky W Reece
MCMiranda J Crouch
Miranda J Crouch
BLBin Luo
Bin Luo
ABAndria D Boone
Andria D Boone
KGKymberly M Gowdy
Kymberly M Gowdy
Exposure to ozone (O3) induces lung injury, pulmonary inflammation, and alters lipid metabolism. During tissue inflammation, specialized pro-resolving lipid mediators (SPMs) facilitate the resolution of inflammation. SPMs regulate the pulmonary immune response during infection and allergic asthma; however, the role of SPMs in O3-induced pulmonary injury and inflammation is unknown. We hypothesize that O3 exposure induces pulmonary inflammation by reducing SPMs. To evaluate this, male C57Bl/6J mice were exposed to filtered air (FA) or 1 ppm O3 for 3 h and necropsied 24 h after exposure. Pulmonary injury/inflammation was determined by bronchoalveolar lavage (BAL) differentials, protein, and lung tissue cytokine expression. SPMs were quantified by liquid chromatography tandem mass spectrometry and SPM receptors leukotriene B4 receptor 1 (BLT-1), formyl peptide receptor 2 (ALX/FPR2), chemokine-like receptor 1 (ChemR23), and SPM-generating enzyme (5-LOX and 12/15-LOX) expression were measured by real time PCR. 24 h post-O3 exposure, BAL PMNs and protein content were significantly increased compared to FA controls. O3-induced lung inflammation was associated with significant decreases in pulmonary SPM precursors (14-HDHA, 17-HDHA), the SPM PDX, and in pulmonary ALX/FPR2, ChemR23, and 12/15-LOX expression. Exogenous administration of 14-HDHA, 17-HDHA, and PDX 1 h prior to O3 exposure rescued pulmonary SPM precursors/SPMs, decreased proinflammatory cytokine and chemokine expression, and decreased BAL macrophages and PMNs. Taken together, these data indicate that O3-mediated SPM reductions may drive O3-induced pulmonary inflammation.

1 March 2013 in Journal of Urology
Verified
Journal Article
Closed access
JHJohanna L. Hannan
Johanna L. Hannan
MAMaarten Albersen
Maarten Albersen
OKOmer Kutlu
Omer Kutlu
CGChristian Gratzke
Christian Gratzke
CSChristian G. Stief
Christian G. Stief
TBTrinity J. Bivalacqua
Trinity J. Bivalacqua
Bilateral cavernous nerve injury results in up-regulation of ROCK signaling in the penis. This is linked to erectile dysfunction in an animal model of post-prostatectomy erectile dysfunction. We evaluated whether daily treatment with the ROCK inhibitor Y-27632 (Tocris Bioscience, Ellisville, Missouri) would prevent erectile dysfunction in a rat model of bilateral cavernous nerve injury. Sprague-Dawley® rats underwent surgery to create sham (14) or bilateral (27) cavernous nerve injury. In the injury group 13 rats received treatment with Y-27632 (5 mg/kg twice daily) and 14 received vehicle. At 14 days after injury, rats underwent cavernous nerve stimulation to determine erectile function. Penes were assessed for neuronal and nitric oxide synthase membrane-endothelial nitric oxide synthase. ROCK2 was assessed by Western blot. Cyclic guanosine monophosphate was determined by enzyme-linked immunosorbent assay. Cavernous homogenates were tested for ROCK and protein kinase G enzymatic activity. Penile apoptosis was evaluated using the Apostain technique (Alexis, San Diego, California). Data were analyzed on ROCK using ANOVA and the t test. While erectile function was decreased in rats with bilateral cavernous nerve injury, daily administration of Y-27632 improved erectile responses. Injury decreased neuronal and nitric oxide synthase membrane-endothelial nitric oxide synthase but ROCK2 was significantly increased. Y-27632 treatment restored neuronal nitric oxide synthase, nitric oxide synthase membrane-endothelial nitric oxide synthase and cyclic guanosine monophosphate levels, and protein kinase G activity. Treatment significantly decreased ROCK2 protein and ROCK activity. There were significantly fewer apoptotic cells after treatment than in injured controls. These results provide evidence for up-regulation of the RhoA/ROCK signaling pathway with detrimental effects on erectile function after bilateral cavernous nerve injury. ROCK inhibition improved erectile dysfunction associated with bilateral cavernous nerve injury by preserving penile nitric oxide bioavailability and decreasing penile apoptosis.

4 May 2015 in Current Drug Targets
Verified
Journal Article
Closed access
PDF file
HMHotaka Matsui
Hotaka Matsui
NSNikolai A. Sopko
Nikolai A. Sopko
JHJohanna L. Hannan
Johanna L. Hannan
TBTrinity J. Bivalacqua
Trinity J. Bivalacqua
Erectile dysfunction (ED) is a major health problem as the population ages. Basic science research for the last two decades has expanded the knowledge on ED and identified several key molecular changes associated with the pathogenesis of ED, including nitric oxide (NO) / cyclic guanosine monophosphate (cGMP) / protein kinase G (PKG) pathway, RhoA/Rho-associated protein kinase (ROCK) signaling pathway, reactive oxygen species (ROS), renin-angiotensin system (RAS) and tumor necrosis factor-alpha (TNF-α). The causes of ED are classified into aging, vasculogenic, neurogenic, endocrinological, drug-induced and psychogenic. ED is often associated with systemic diseases, such as diabetes and cardiovascular diseases. In this review, we will review the molecular mechanisms of ED and known mechanisms behind ED associated with systemic diseases.

1 August 2016 in The Journal of Sexual Medicine
Verified
Journal Article
Closed access
CPCarol A. Podlasek
Carol A. Podlasek
JMJohn Mulhall
John Mulhall
KDKelvin Davies
Kelvin Davies
CWChristopher J. Wingard
Christopher J. Wingard
JHJohanna L. Hannan
Johanna L. Hannan
ABArthur L. Burnett
Arthur L. Burnett
Introduction: The biological importance of testosterone is generally accepted by the medical community; however, controversy focuses on its relevance to sexual function and the sexual response, and our understanding of the extent of its role in this area is evolving. Aim: To provide scientific evidence examining the role of testosterone at the cellular and molecular levels as it pertains to normal erectile physiology and the development of erectile dysfunction and to assist in guiding successful therapeutic interventions for androgen-dependent sexual dysfunction. Methods: In this White Paper, the Basic Science Committee of the Sexual Medicine Society of North America assessed the current basic science literature examining the role of testosterone in sexual function and dysfunction. Results: Testosterone plays an important role in sexual function through multiple processes: physiologic (stimulates activity of nitric oxide synthase), developmental (establishes and maintains the structural and functional integrity of the penis), neural (development, maintenance, function, and plasticity of the cavernous nerve and pelvic ganglia), therapeutically for dysfunctional regulation (beneficial effect on aging, diabetes, and prostatectomy), and phosphodiesterase type 5 inhibition (testosterone supplement to counteract phosphodiesterase type 5 inhibitor resistance). Conclusion: Despite controversies concerning testosterone with regard to sexual function, basic science studies provide incontrovertible evidence for a significant role of testosterone in sexual function and suggest that properly administered testosterone therapy is potentially advantageous for treating male sexual dysfunction.